Skip to main content
Back to Menlo Ventures

Menlo Ventures's Pharmaceutical Portfolio

Browse 5 Pharmaceutical companies funded by Menlo Ventures. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
5
Total Funding in Pharmaceutical
$517.8M

Pharmaceutical Portfolio Companies (5)

Export
BiotechnologyLife ScienceMachine LearningPharmaceutical

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Lexington, United States
June 2022
$30.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Salt Lake City, United States
June 2024
$200.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsPharmaceuticalRecruitingTherapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

South San Francisco, United States
January 2023
$287.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareHealth InsuranceHome Health CarePharmaceuticalTherapeutics

Ophelia offers medication and support for quitting opioids.

New York, United States
December 2021
Series B

Founder Contacts

30,000+ verified contacts

Health CareHealth InsuranceLife InsurancePharmaceutical

Health IQ is an insurance provider with affordable insurance rates based on customers lifestyle.

Mountain View, United States
January 2022
$287K
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Explore Menlo Ventures's Full Portfolio

View all companies funded by Menlo Ventures across every industry and funding stage.

View Full Menlo Ventures Portfolio